Join our newsletter. Sign up today

News

Publications and related articles about Lunaphore Technologies and the industry in general.

Lunaphore at the 7th Immunotherapy of Cancer Conference


The 7th Immunotherapy of Cancer Conference is going virtual and Lunaphore is participating in the event. Featuring the latest developments in cancer immunotherapy, the conference represents a global forum for discussion of translational research in the field of immuno-oncology.

Our products and technology for in-situ tissue analytics will be featured in a LIVE Satellite Symposium as well as in an ePoster presentation.

Joining the two presentations you will learn more on:

  • The key features of our microfluidic precision circuit combined with instantaneous temperature control;
  • How we automate staining and imaging of hyper-plex immunofluorescence assays;
  • How to perform immunofluorescence multiplexing in short timeframes using off-the-shelf, label-free antibodies.

Can’t attend? Fill in this form and we will send you a link to the recordings after the event.


LIVE Satellite Symposium
“Rapid hyper-plex staining and simultaneous imaging for immunophenotyping of tissue sections”

Speaker: Diego Dupouy, Ph.D.
When: 3 Oct 2020 | 11:45 CEST – afterwards on-demand.

Abstract
The simultaneous detection of biomarkers on tissue samples plays a fundamental role in the study of the tumor microenvironment. Multiplexed immunofluorescence tools have demonstrated to be key enablers in these endeavors. Available techniques to perform high-plex staining require intensive manual handling, are highly time-consuming or require special labeling of primary antibodies. Here we present a highly automated, extremely rapid hyper-plex approach to stain and image tissue samples using label-free primary antibodies in combination with off-the-shelf fluorescently labeled secondary antibodies.

ePoster presentation
“Fast automated microfluidic-based multiplexed immunofluorescence for tumor microenvironment analysis”

Speaker: Alexandre Kehren, M.Sc.
When: On-demand, 2-3 Oct 2020 | P03.07

Abstract
Immuno-oncology and targeted molecular therapies have acquired a central role in the treatment of multiple cancers. Consequently, high-throughput biomarker analysis and tumor immune profiling have seen increased demand. Multiplexed immunoassays are a powerful tool to address these needs, but still time- and resource-consuming. Here we present how we developed a fast and automated high-plex fluorescent immunostaining procedure, using a microfluidic-based device, that can be easily implemented as a routine assay.


Do you want to know more?

Click on the button below and one of our representatives will get in touch with you.

Ask our team


Categories: News

Share this

Hi! We use cookies to improve this website. By continuing to use our services, you are giving us your consent to use cookies. Learn more about our privacy policy and our terms of use.
I agree